Factors for increased morbidity and mortality in uremia: hyperphosphatemia. | Semin Nephrol;24(5): 396-400, 2004 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL TCIM Americas

Traditional, Complementary and Integrative Medicine in the Americas VHL

Subject descriptor lookup Advanced Search

Factors for increased morbidity and mortality in uremia: hyperphosphatemia.

Levin, Nathan W; Gotch, Frank A; Kuhlmann, Martin K.

Affiliation

Levin NW; Renal Research Institute, New York, NY 10128, USA. nlevin@rriny.com

Semin Nephrol ; 24(5): 396-400, 2004 Sep.

Article in En | MEDLINE | ID: mdl-15490397

Subject(s)

Phosphorus Metabolism Disorders/blood; Phosphorus Metabolism Disorders/mortality; Uremia/complications; Humans; Phosphorus/pharmacokinetics; Phosphorus Metabolism Disorders/etiology; Phosphorus Metabolism Disorders/therapy; Renal Dialysis

Search on Google

Database: MEDLINE Main subject: Phosphorus Metabolism Disorders / Uremia Type of study: Etiology_studies / Prognostic_studies Language: En Journal: Semin Nephrol Year: 2004 Type: Article Affiliation country: United States

Search on Google

Database: MEDLINE Main subject: Phosphorus Metabolism Disorders / Uremia Type of study: Etiology_studies / Prognostic_studies Language: En Journal: Semin Nephrol Year: 2004 Type: Article Affiliation country: United States